CLINICAL_TRIALS
trial_result
· 2016-12-05
Clinical Trial Update: BAX 855 Pediatric Study [Phase 3]
Summary
Phase 3 pediatric study of BAX 855 for Hemophilia A completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2016-12-05